Bone Substitute Effect on Vascularization and Bone Remodeling after Application of phVEGF165 Transfected BMSC

VEGF (vascular endothelial growth factor) promotes vascularization and remodeling of bone substitutes. The aim of this study was to examine the effect of distinct resorbable ceramic carriers on bone forming capacities of VEGF transfected bone marrow stromal cells (BMSC). A critical size defect of the radius in rabbits was filled either by a low surface scaffold called beta-TCP (tricalciumphsphate) or the high surface scaffold CDHA (calcium deficient hydroxy-apatite) loaded with autologous BMSC, which were either transfected with a control plasmid or a plasmid coding for phVEGF165. They were compared to unloaded scaffolds. Thus, six treatment groups (n = 6 in each group) were followed by X-ray over 16 weeks. After probe retrieval, the volume of new bone was measured by micro-CT scans and vascularization was assessed in histology. While only minor bone formation was found in both carriers when implanted alone, BMSC led to increased osteogenesis in both carriers. VEGF promoted vascularization of the scaffolds significantly in contrast to BMSC alone. Bone formation was increased in the beta-TCP group, whereas it was inhibited in the CDHA group that showed faster scaffold degradation. The results indicate that the interaction of VEGF transfected BMSC with resorbable ceramic carrier influences the ability to promote bone healing.

[1]  C. Verfaillie,et al.  Erratum:Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001; 98:2615-2625 , 2009 .

[2]  Shien‐Fong Lin,et al.  rhVEGF 165 delivered in a porous beta-tricalcium phosphate scaffold accelerates bridging of critical-sized defects in rabbit radii. , 2009, Journal of biomedical materials research. Part A.

[3]  P. Kasten,et al.  The effect of platelet-rich plasma on healing in critical-size long-bone defects. , 2008, Biomaterials.

[4]  L Claes,et al.  VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. , 2007, Bone.

[5]  T. Buckland,et al.  Comparative performance of three ceramic bone graft substitutes. , 2007, The spine journal : official journal of the North American Spine Society.

[6]  D. Marsh,et al.  Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX, in association with autologous osteogenic cells and growth factors. , 2007, Bone.

[7]  S. Kakar,et al.  New technologies for the enhancement of skeletal repair. , 2007, Injury.

[8]  J. McClellan,et al.  Vertebral Bone Resorption After Transforaminal Lumbar Interbody Fusion With Bone Morphogenetic Protein (rhBMP-2) , 2006, Journal of spinal disorders & techniques.

[9]  Christina Eckhardt,et al.  Vascular Endothelial Growth Factor Gene‐Activated Matrix (VEGF165‐GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone Defects , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Johnny Huard,et al.  VEGF Improves, Whereas sFlt1 Inhibits, BMP2‐Induced Bone Formation and Bone Healing Through Modulation of Angiogenesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Philip Kasten,et al.  Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. , 2005, Biomaterials.

[12]  Linda G Griffith,et al.  Engineering principles of clinical cell-based tissue engineering. , 2004, The Journal of bone and joint surgery. American volume.

[13]  R G Richards,et al.  Immunohistochemistry of matrix markers in Technovit 9100 New-embedded undecalcified bone sections. , 2003, European cells & materials.

[14]  Timo Jämsä,et al.  Adenoviral VEGF‐A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues , 2003, The journal of gene medicine.

[15]  C Krettek,et al.  Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix. , 2003, Biomaterials.

[16]  V. Kosma,et al.  Adenovirus‐mediated VEGF‐A gene transfer induces bone formation in vivo , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Toshitaka Nakamura,et al.  Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. , 2003, Bone.

[18]  J. Pelisek,et al.  Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs. , 2002, Acta physiologica Scandinavica.

[19]  H. Redmond,et al.  Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Jalovaara,et al.  Composite Implant of Native Bovine Bone Morphogenetic Protein (BMP) and Biocoral in the Treatment of Scaphoid Nonunions — A Preliminary Study , 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

[21]  R. Legeros,et al.  Properties of osteoconductive biomaterials: calcium phosphates. , 2002, Clinical orthopaedics and related research.

[22]  C. Verfaillie,et al.  Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. , 2001, Blood.

[23]  I. Asahina,et al.  Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. , 2001, Biomaterials.

[24]  S. Nikol,et al.  Preclinical and clinical experience in vascular gene therapy: advantages over conservative/standard therapy. , 2001, The Journal of invasive cardiology.

[25]  M Bohner,et al.  Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements. , 2000, Injury.

[26]  A. Meunier,et al.  Coral grafting supplemented with bone marrow. , 1999, The Journal of bone and joint surgery. British volume.

[27]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[28]  J. Glowacki.  Angiogenesis in fracture repair. , 1998, Clinical orthopaedics and related research.

[29]  U. Wikesjö,et al.  Periodontal repair in dogs: guided tissue regeneration enhances bone formation in sites implanted with a coral-derived calcium carbonate biomaterial. , 2005, Journal of clinical periodontology.

[30]  P. Jalovaara,et al.  Composite implant of native bovine bone morphogenetic protein (BMP), collagen carrier and biocoral in the treatment of resistant ulnar nonunions: report of five preliminary cases , 2003, Archives of Orthopaedic and Trauma Surgery.

[31]  I. Asahina,et al.  Comparative study of biphasic calcium phosphate ceramics impregnated with rhBMP-2 as bone substitutes. , 2001, Journal of biomedical materials research.

[32]  K. Thorngren,et al.  Osteogenetic properties of reimplanted decalcified and undecalcified autologous bone in the rabbit radius. , 1982, Scandinavian journal of plastic and reconstructive surgery.